Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
A 2019 network meta-analysis of 233 trials (n = 147,710) reported elevated risks of dizziness (odds ratios [ORs] 1.92, 1.57, 1.40) and headache (ORs 1.34, 1.41, 1.18) with GLP-1 RAs versus insulin, thiazolidinediones, and placebo 40
Product Notes
Peptide Sequence: Nle-Asp(1)-His-D-Phe-Arg-Trp-Lys(1) Molecular Formula: CHNO Molecular Weight: 1024.198 g/mol PubChem CID: 92432 CAS Number: 121062-08-6 Source: PubChem In laboratory models, MTII may be used to investigate melanocortin receptor activity, signal transduction, and pigment-pathway responses
Dihydroberberine, a hydrogenated derivative of berberine firstly identified in Phellodendri Chinese cortex, exerts anti-inflammatory effect via dual modulation of NF-B and MAPK signaling pathways
US$ 22.92
US$ 29.47
US$ 22.33
US$ 29.94
US$ 22.70
US$ 27.78
